184 related articles for article (PubMed ID: 30081883)
41. The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis.
Li M; Ma G; Li X; Zhou Q
Med Sci Monit; 2022 Jul; 28():e936898. PubMed ID: 35891604
[TBL] [Abstract][Full Text] [Related]
42. Clinical significance of cancer-associated fibroblasts and their correlation with microvessel and lymphatic vessel density in lung adenocarcinoma.
Chen L; Qin Y; Zhang T; Ding N; Chen Y; Zhang Z; Guo C
J Clin Lab Anal; 2019 May; 33(4):e22832. PubMed ID: 30737838
[TBL] [Abstract][Full Text] [Related]
43. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
44. Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients.
Chen X; Wan J; Liu J; Xie W; Diao X; Xu J; Zhu B; Chen Z
Lung Cancer; 2010 Sep; 69(3):348-54. PubMed ID: 20022135
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
[TBL] [Abstract][Full Text] [Related]
46. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Yang SL; Ren QG; Wen L; Hu JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
[TBL] [Abstract][Full Text] [Related]
48. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
Berghmans T; Dusart M; Paesmans M; Hossein-Foucher C; Buvat I; Castaigne C; Scherpereel A; Mascaux C; Moreau M; Roelandts M; Alard S; Meert AP; Patz EF; Lafitte JJ; Sculier JP;
J Thorac Oncol; 2008 Jan; 3(1):6-12. PubMed ID: 18166834
[TBL] [Abstract][Full Text] [Related]
49. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
[TBL] [Abstract][Full Text] [Related]
50. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.
Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R
Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680
[TBL] [Abstract][Full Text] [Related]
51. Intratumoral vessel density as prognostic factors in head and neck squamous cell carcinoma: a meta-analysis of literature.
Yu M; Liu L; Liang C; Li P; Ma X; Zhang Q; Wei Y
Head Neck; 2014 Apr; 36(4):596-602. PubMed ID: 23780885
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis.
Zhang H; Gao L; Zhang B; Zhang L; Wang C
Sci Rep; 2016 Mar; 6():22618. PubMed ID: 26939789
[TBL] [Abstract][Full Text] [Related]
53. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
Hu L; Zhang P; Mei Q; Sun W; Zhou L; Yin T
BMC Cancer; 2020 May; 20(1):424. PubMed ID: 32408907
[TBL] [Abstract][Full Text] [Related]
54. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma.
Coşkun U; Akyürek N; Dursun A; Yamaç D
J Surg Res; 2010 Nov; 164(1):110-5. PubMed ID: 19628230
[TBL] [Abstract][Full Text] [Related]
55. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma.
Chen L; Chen M; Han Z; Jiang F; Xu C; Qin Y; Ding N; Liu Y; Zhang T; An Z; Guo C
J Clin Pathol; 2018 Aug; 71(8):721-728. PubMed ID: 29559517
[TBL] [Abstract][Full Text] [Related]
56. Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma.
Brundler MA; Harrison JA; de Saussure B; de Perrot M; Pepper MS
J Clin Pathol; 2006 Feb; 59(2):191-5. PubMed ID: 16443737
[TBL] [Abstract][Full Text] [Related]
57. Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis.
Wu H; Qi XW; Yan GN; Zhang QB; Xu C; Bian XW
PLoS One; 2014; 9(6):e100168. PubMed ID: 24940615
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of the frequency of vascular invasion in stage I non-small cell lung cancer.
Okada S; Mizuguchi S; Izumi N; Komatsu H; Toda M; Hara K; Okuno T; Shibata T; Wanibuchi H; Nishiyama N
Gen Thorac Cardiovasc Surg; 2017 Jan; 65(1):32-39. PubMed ID: 27738881
[TBL] [Abstract][Full Text] [Related]
59. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.
Hashizume S; Nagayasu T; Hayashi T; Hidaka S; Tsuchiya T; Tagawa T; Yamasaki N; Furukawa K; Matsumoto K; Miyazaki T
Lung Cancer; 2009 Sep; 65(3):363-70. PubMed ID: 19157635
[TBL] [Abstract][Full Text] [Related]
60. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]